146 related articles for article (PubMed ID: 18620939)
1. Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.
Mariani S; Giona F; Basciani S; Brama M; Gnessi L
Lancet; 2008 Jul; 372(9633):111-112. PubMed ID: 18620939
[No Abstract] [Full Text] [Related]
2. Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.
Zhao D; Wang G; Li C; Meng L
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):145-146. PubMed ID: 21336741
[No Abstract] [Full Text] [Related]
3. Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.
Giona F; Mariani S; Gnessi L; Moleti ML; Rea M; De Vellis A; Marzella D; Testi AM; Foà R
Haematologica; 2013 Mar; 98(3):e25-7. PubMed ID: 22983586
[No Abstract] [Full Text] [Related]
4. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.
Arora B; Kumar L; Sharma A; Wadhwa J; Kochupillai V
Ann Oncol; 2004 Feb; 15(2):358-9. PubMed ID: 14760137
[No Abstract] [Full Text] [Related]
5. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Parmar KK; King RS
Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324
[No Abstract] [Full Text] [Related]
6. Imatinib mesylate induced immune thrombocytopenia.
Rajappa S; Varadpande L; Paul TR; Digumarti R
Leuk Lymphoma; 2007 Nov; 48(11):2261-3. PubMed ID: 17926182
[No Abstract] [Full Text] [Related]
7. Imatinib mesylate.
Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
[No Abstract] [Full Text] [Related]
8. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
[No Abstract] [Full Text] [Related]
9. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
Yamazaki R; Okamoto S; Chen CK; Tada S; Saito H; Shibata R; Sakamoto M; Mori T; Ikeda Y
Leuk Lymphoma; 2006 Jul; 47(7):1427-30. PubMed ID: 16923586
[No Abstract] [Full Text] [Related]
10. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
Ostro D; Lipton J
Leuk Lymphoma; 2007 Jan; 48(1):195-6. PubMed ID: 17325868
[No Abstract] [Full Text] [Related]
11. Precipitation of porphyria cutanea tarda by imatinib mesylate?
Ho AY; Deacon A; Osborne G; Mufti GJ
Br J Haematol; 2003 Apr; 121(2):375. PubMed ID: 12694262
[No Abstract] [Full Text] [Related]
12. Gleevec: tailoring to fit.
May TS
Drug Discov Today; 2003 Mar; 8(5):188-9. PubMed ID: 12634004
[No Abstract] [Full Text] [Related]
13. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
Prabhash K; Biswas G; Prasad N; Karant N; Sastry PS; Parikh PM
Indian J Dermatol Venereol Leprol; 2006; 72(1):63-4. PubMed ID: 16481719
[No Abstract] [Full Text] [Related]
14. [Imatinib mesylate-induced acute cytolytic hepatitis].
Rocca P; El Jastimi S; Troncy J; Scoazec JY; Boucher A; Vial T; Trépo C; Zoulim F
Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):918-9. PubMed ID: 15523233
[No Abstract] [Full Text] [Related]
15. Leukemia. Q&A highlights.
Frame D; Sessions J; Fausel C
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S22. PubMed ID: 18056929
[No Abstract] [Full Text] [Related]
16. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
17. A patient of chronic myelogenous leukemia developing painful rash on feet.
Kumar P; Das NK; Sil A; Chakrabarti P
J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
[No Abstract] [Full Text] [Related]
18. A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.
Suemori K; Fujiwara H; Watanabe S; Azuma T; Yasukawa M
Int J Hematol; 2010 Dec; 92(5):777-8. PubMed ID: 21110146
[No Abstract] [Full Text] [Related]
19. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
Druker BJ
Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592
[TBL] [Abstract][Full Text] [Related]
20. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
Georgalas I; Pavesio C; Ezra E
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1585-6. PubMed ID: 17562067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
